Study Evaluation LXR-623 in Healthy Adults

A Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of LXR-623 Administered Orally to Healthy Subjects

To evaluate the safety and tolerability of multiple doses of LXR in healthy adults.

Inclusion Criteria:

• Generally healthy adults.
• Liver function tests, triglycerideres, and creatinine must be below upper limit of normal at screening.

Exclusion Criteria:

• A history or active presence of clinically important medical disease.
• Any metal implants or devices.
• Claustrophobia.